Debabrata Mukhopadhyay

Title: Debabrata Mukhopadhyay: Innovator in Anti-Cancer Research

Introduction

Debabrata Mukhopadhyay is a prominent inventor based in Rochester, MN (US). He has made significant contributions to the field of anti-cancer research, holding a total of six patents. His work focuses on developing innovative solutions for cancer treatment, particularly through the use of novel compounds and formulations.

Latest Patents

Among his latest patents is the invention of nimbolide analogs as anti-cancer agents. This invention relates to nimbolide analogs that are useful in combating cancer, particularly those of a specific general formula. The invention details various structural components that can be modified to enhance efficacy. Another notable patent involves a method for regressing pancreatic tumors using a liposomal formulation combined with DNA vaccines. This innovative approach utilizes a Plectin-1 receptor targeting cationic lipopeptide, which is designed to deliver therapeutic agents effectively.

Career Highlights

Debabrata Mukhopadhyay has worked with esteemed organizations such as the Mayo Foundation for Medical Education and Research and the Council of Scientific & Industrial Research. His experience in these institutions has allowed him to collaborate on groundbreaking research and development projects aimed at improving cancer therapies.

Collaborations

Throughout his career, Mukhopadhyay has collaborated with notable colleagues, including Priyabrata Mukherjee and Mark R Spaller. These partnerships have contributed to the advancement of his research and the successful development of his patented inventions.

Conclusion

Debabrata Mukhopadhyay's innovative work in anti-cancer research exemplifies the impact of dedicated inventors in the medical field. His contributions continue to pave the way for new treatment options and improved patient outcomes.